From: A computational approach to design a multiepitope vaccine against H5N1 virus
Allele | Epitope sequence | Epitope length | Percent of protein sequence m atches at identity <  = 100% | Minim um identity (%) | Maxim um identity (%) |
---|---|---|---|---|---|
HA Protein | Â | Â | Â | Â | Â |
HLA-A0101 | KSDQICIGY | 9 | 99.00% (99/100) | 88.89 | 100.00 |
HLA-A3101 | RLVPKIATR | 9 | 82.00% (82/100) | 66.67 | 100.00 |
HLA-A3201 | RMEFFWTIL | 9 | 96.00% (96/100) | 88.89 | 100.00 |
HLA-A3207 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-A3215 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-A6601 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-A6823 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B0801 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B1402 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B2705 | GRMEFFWTI | 9 | 95.00% (95/100) | 88.89 | 100.00 |
HLA-B2720 | GRMEFFWTI | 9 | 95.00% (95/100) | 88.89 | 100.00 |
HLA-B3501 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B3503 | CPYLGSPSF | 9 | 88.00% (88/100) | 77.78 | 100.00 |
HLA-B3801 | FHNIHPLTI | 9 | 99.00% (99/100) | 88.89 | 100.00 |
HLA-B3901 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B4013 | RMEFFWTIL | 9 | 96.00% (96/100) | 88.89 | 100.00 |
HLA-B4201 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B4402 | MENERTLDF | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B4403 | MENERTLDF | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B4801 | RMEFFWTIL | 9 | 96.00% (96/100) | 88.89 | 100.00 |
HLA-B5101 | CPYLGSPSF | 9 | 88.00% (88/100) | 77.78 | 100.00 |
HLA-B5301 | CPYLGSPSF | 9 | 88.00% (88/100) | 77.78 | 100.00 |
HLA-B5401 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-B5801 | QSGRMEFFW | 9 | 99.00% (99/100) | 77.78 | 100.00 |
HLA-B5802 | QSGRMEFFW | 9 | 99.00% (99/100) | 77.78 | 100.00 |
HLA-B8301 | MPFHNIHPL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
DRB1_0103 | NLYDKVRLQLRDNAK | 15 | 96.00% (96/100) | 93.33 | 100.00 |
DRB1_0301 | ELLVLMENERTLDFH | 15 | 100.00% (100/100) | 100.00 | 100.00 |
DRB1_0401 | PTTYISIGTSTLNQR | 15 | 83.00% (83/100) | 93.33 | 100.00 |
DRB1_0405 | AELLVLMENERTLDF | 15 | 100.00% (100/100) | 100.00 | 100.00 |
DRB4_0101 | LYDKVRLQLRDNAKE | 15 | 96.00% (96/100) | 93.33 | 100.00 |
HLA-DQA10501-DQB10301 | PTTYISIGTSTLNQR | 15 | 83.00% (83/100) | 93.33 | 100.00 |
NA Protein | Â | Â | Â | Â | Â |
HLA-A0202 | HLECRIFFL | 9 | 2.00% (2/100) | 88.89 | 100.00 |
HLA-A0206 | LQIGNIISI | 9 | 6.00% (6/100) | 66.67 | 100.00 |
HLA-A0207 | GLDCIRPCF | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-A0211 | ITIGSICMV | 9 | 95.00% (95/100) | 88.89 | 100.00 |
HLA-A0212 | LQIGNIISI | 9 | 6.00% (6/100) | 66.67 | 100.00 |
HLA-A0217 | HLECRIFFL | 9 | 2.00% (2/100) | 88.89 | 100.00 |
HLA-A2301 | AYGVKGFSF | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-A2402 | AYGVKGFSF | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-A2601 | MVIGMVSLM | 9 | 2.00% (2/100) | 77.78 | 100.00 |
HLA-A2602 | MVIGMVSLM | 9 | 2.00% (2/100) | 77.78 | 100.00 |
HLA-A2902 | GVKGFSFKY | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-A3002 | GVKGFSFKY | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-A6601 | MVIGMVSLM | 9 | 2.00% (2/100) | 77.78 | 100.00 |
HLA-B0802 | HLECRIFFL | 9 | 2.00% (2/100) | 88.89 | 100.00 |
HLA-B0803 | HLECRIFFL | 9 | 2.00% (2/100) | 88.89 | 100.00 |
HLA-B1501 | YQIGYICSG | 9 | 99.00% (99/100) | 88.89 | 100.00 |
HLA-B4001 | LEYQIGYIC | 9 | 99.00% (99/100) | 88.89 | 100.00 |
HLA-B4002 | LEYQIGYIC | 9 | 99.00% (99/100) | 88.89 | 100.00 |
HLA-B4801 | CMVIGMVSL | 9 | 2.00% (2/100) | 77.78 | 100.00 |
HLA-C0702 | IRPCFWVEL | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-C0802 | FSFKYGNGV | 9 | 100.00% (100/100) | 100.00 | 100.00 |
HLA-C1203 | FSFKYGNGV | 9 | 100.00% (100/100) | 100.00 | 100.00 |
DRB1_0403 | TIGSICMVIGMVSLM | 15 | 2.00% (2/100) | 86.67 | 100.00 |
HLA-DQA10102-DQB10501 | ICMVIGMVSLMLQIG | 15 | 2.00% (2/100) | 86.67 | 100.00 |
HLA-DQA10103-DQB10603 | GSICMVIGMVSLMLQ | 15 | 2.00% (2/100) | 86.67 | 100.00 |